Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Eliaz |
Description | ET collaborates with Terumo Blood Cell Changing the course of life-threatening diseases by increasing survival and improving overall health and quality of |
Keywords | N/A |
WebSite | eliaztherapeutics.com |
Host IP | 99.83.190.102 |
Location | United States |
Site | Rank |
US$1,430,782
Last updated: 2023-04-29 05:14:25
eliaztherapeutics.com has Semrush global rank of 7,397,570. eliaztherapeutics.com has an estimated worth of US$ 1,430,782, based on its estimated Ads revenue. eliaztherapeutics.com receives approximately 165,091 unique visitors each day. Its web server is located in United States, with IP address 99.83.190.102. According to SiteAdvisor, eliaztherapeutics.com is safe to visit. |
Purchase/Sale Value | US$1,430,782 |
Daily Ads Revenue | US$1,321 |
Monthly Ads Revenue | US$39,622 |
Yearly Ads Revenue | US$475,460 |
Daily Unique Visitors | 11,007 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
eliaztherapeutics.com. | A | 3599 | IP: 99.83.190.102 |
eliaztherapeutics.com. | A | 3599 | IP: 75.2.70.75 |
eliaztherapeutics.com. | NS | 3600 | NS Record: ns1a.dodns.net. |
eliaztherapeutics.com. | NS | 3600 | NS Record: ns2a.dodns.net. |
eliaztherapeutics.com. | MX | 600 | MX Record: 10 wooden-spoon-mx.email-protect.gosecure.net. |
eliaztherapeutics.com. | TXT | 1800 | TXT Record: google-site-verification=wOUAyNVVLzKMAzhuMTqfULt-_98LpW6ukzuAv6VN9H4 |
eliaztherapeutics.com. | TXT | 1800 | TXT Record: v=spf1 mx ip4:208.80.200.0/21 include:spf.intermedia.net include:_spf.google.com include:sendgrid.net ~all |
About Management Scientific Advisory Board Press Room Technology Problem + solution X-GAL-3 DEVICE INVESTOR RELATIONS INTELLECTUAL PROPERTY RESEARCH Research FCOI Contact US LATEST PRESS RELEASE ET collaborates with Terumo Blood Cell Technologies Upcoming development and commercialization of a novel therapeutic apheresis treatment for acute kidney injury (AKI) Learn More NEWSROOM ETI Awarded $1.7 million by NIH For XGAL-3s Apheresis Large Animal Safety Study Learn More _ mission + target Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis. Our mission is to change the course of life-threatening diseases to improve survival and prevent long-term disease and disability. The Problem Acute Kidney Injury (AKI) is a common and potentially life-threatening condition. AKI affects over 4 million people in the United States with an annual cost of up to $24.0 billion. Despite efforts to develop new therapeutic modalities, current therapeutic options remain |
HTTP/1.1 301 Moved Permanently Server: openresty Date: Fri, 22 Oct 2021 04:13:37 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://eliaztherapeutics.com/ HTTP/2 301 server: openresty date: Fri, 22 Oct 2021 04:13:37 GMT content-type: text/html content-length: 166 location: https://www.eliaztherapeutics.com/ HTTP/2 200 server: openresty date: Fri, 22 Oct 2021 04:13:37 GMT content-type: text/html content-length: 16120 via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 0 x-served-by: cache-dca17731-DCA, cache-wdc5575-WDC x-cache: MISS, MISS x-cache-hits: 0, 0 x-timer: S1634876018.886318,VS0,VE74 vary: Accept-Encoding x-cluster-name: us-east-1-prod-edge-eks-15 |
Domain Name: ELIAZTHERAPEUTICS.COM Registry Domain ID: 1961614923_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.udag.net Registrar URL: http://www.united-domains.de Updated Date: 2021-08-01T06:28:41Z Creation Date: 2015-09-18T23:46:29Z Registry Expiry Date: 2021-09-18T23:46:29Z Registrar: United-Domains AG Registrar IANA ID: 1408 Registrar Abuse Contact Email: abuse@united-domains.de Registrar Abuse Contact Phone: +49.8151368670 Domain Status: ok https://icann.org/epp#ok Name Server: NS1A.DODNS.NET Name Server: NS2A.DODNS.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T21:16:43Z <<< |